Earnings History Data for Surface Oncology, Inc. (SURF) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Surface Oncology, Inc.

Surface Oncology, Inc. is a clinical-stage immuno-oncology company. It develops therapies for the treatment of cancer. The company's product pipeline includes CD47, CD73, SRF231, SRF373, SRF617, SRF388 and SRF231 which are in clinical stage. Surface Oncology is based in Cambridge, Massachusetts.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
04-05-2023 PM SURF Surface Oncology 35.00 -0.33 -0.37 0.00 Surface Oncology GAAP EPS of -$0.33 beats by $0.04
[5/4/2023 9:39 AM]		 0.57 -0.01 
(-1.72%)		 0.0 0.0 
(0.00%)		 0.56 - 2.51 143,065 160,000 0
09-03-2023 PM SURF Surface Oncology, Inc. 27.97 -0.35 -0.41 -0.52 Surface Oncology GAAP EPS of -$0.35 misses by $0.03
[3/9/2023 7:16 AM]		 0.73 0.07 
(10.94%)		 0.0 0.0 
(0.00%)		 0.60 - 3.25 280,453 210,000 0
03-08-2022 PM 7:10 AM ET
(Aug 3)		 SURF Surface Oncology 90.00 -0.46 -0.44 0.00 Surface Oncology GAAP EPS of -$0.46 misses by $0.01
[8/3/2022 7:56 AM]		 1.71 0.05 
(3.01%)		 1.67 0.01 
(0.60%)		 1.37 - 8.38 874,622 390,000 1,432
09-05-2022 PM 7:10 AM ET
(May 9)		 SURF Surface Oncology 125.00 0.13 -0.48 0.00 Surface Oncology GAAP EPS of $0.13 beats by $0.38, revenue of $30M beats by $17.42M
[5/9/2022 7:38 AM]		 1.97 -0.12 
(-5.98%)		 2.11 0.02 
(0.96%)		 1.93 - 9.57 1,506,303 750,000 16,819
02-03-2022 PM 7:10 AM ET
(Mar 2)		 SURF Surface Oncology 166.00 -0.52 -0.10 0.00 Surface Oncology GAAP EPS of -$0.52 misses by $0.43, revenue of $0.15M misses by $16.18M
[3/2/2022 7:42 AM]		 3.36 -0.28 
(-7.69%)		 3.57 -0.07 
(-1.92%)		 3.10 - 9.79 513,555 420,000 952
04-11-2021 PM SURF Surface Oncology 347.00 -0.44 -0.36 0.00 Surface Oncology EPS misses by $0.04, beats on revenue
[11/4/2021 8:16 AM]		 7.75 0.03 
(0.39%)		 7.75 0.0 
(0.00%)		 4.95 - 14.40 509,362 430,000 7,973
05-08-2021 PM SURF Surface Oncology, Inc. 254.00 -0.44 -0.31 0.00 Surface Oncology EPS misses by $0.09, misses on revenue
[8/5/2021 8:46 AM]		 5.60 0.44 
(8.53%)		 5.21 0.05 
(0.97%)		 4.95 - 14.40 1,366,293 950,000 13,733
05-05-2021 PM SURF Surface Oncology, Inc. 318.00 -0.37 -0.40 0.00 Surface Oncology EPS beats by $0.04, beats on revenue
[5/5/2021 6:55 AM]		 7.25 0.20 
(2.84%)		 7.25 0.0 
(0.00%)		 2.39 - 14.40 1,230,967 930,000 5,149
09-03-2021 PM SURF Surface Oncology, Inc. 299.30 1.56 0.35 -0.57 Surface Oncology EPS beats by $1.31, beats on revenue
[3/9/2021 7:35 AM]		 8.27 0.91 
(12.36%)		 8.42 1.06 
(14.40%)		 1.38 - 14.40 3,052,062 1,506,489 333,930
10-11-2020 PM SURF Surface Oncology, Inc. 378.71 -0.39 -0.41 -0.61 Surface Oncology reports Q3 results
[11/10/2020 6:26 AM]		 9.00 0.28 
(3.21%)		 8.70 -0.02 
(-0.23%)		 1.38 - 10.25 547,856 466,138 537
11-08-2020 PM SURF Surface Oncology, Inc. 233.13 -0.44 -0.51 -0.64 Surface Oncology EPS beats by $0.07
[8/11/2020 6:35 AM]		 5.87 -0.08 
(-1.34%)		 0.0 0.0 
(0.00%)		 1.15 - 7.66 375,778 782,511 0
12-05-2020 PM SURF Surface Oncology, Inc. 73.80 0.74 0.20 -0.15 Surface Oncology EPS beats by $0.54, beats on revenue
[5/12/2020 6:27 AM]		 2.69 0.08 
(3.07%)		 0.0 0.0 
(0.00%)		 1.15 - 4.23 49,733 83,970 0